Francisco Javier González Rico

Dr. Francisco Javier González Rico


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
BMBeatriz Marín-Díaz
Beatriz Marín-Díaz
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
JMJaime M. Merino
Jaime M. Merino
FRFrancisco Javier González Rico
Francisco Javier González Rico
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
The aryl hydrocarbon receptor (AHR) is a markedly established regulator of a plethora of cellular and molecular processes. Its initial role in the detoxification of xenobiotic compounds has been partially overshadowed by its involvement in homeostatic and organ physiology processes. In fact, the discovery of its ability to bind specific target regulatory sequences has allowed for the understanding of how AHR modulates such processes. Thereby, AHR presents functions in transcriptional regulation, chromatin architecture modifications and participation in different key signaling pathways. Interestingly, such fields of influence end up affecting organ and tissue homeostasis, including regenerative response both to endogenous and exogenous stimuli. Therefore, from classical spheres such as canonical transcriptional regulation in embryonic development, cell migration, differentiation or tumor progression to modern approaches in epigenetics, senescence, immune system or microbiome, this review covers all aspects derived from the balance between regulation/deregulation of AHR and its physio-pathological consequences.

7 April 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
CRClaudia Rejano-Gordillo
Claudia Rejano-Gordillo
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
ANAna Nacarino-Palma
Ana Nacarino-Palma
JMJaime M. Merino
Jaime M. Merino
FRFrancisco Javier González Rico
Francisco Javier González Rico
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
Transcription factor aryl hydrocarbon receptor (AHR) has emerged as one of the main regulators involved both in different homeostatic cell functions and tumor progression. Being a member of the family of basic-helix-loop-helix (bHLH) transcriptional regulators, this intracellular receptor has become a key member in differentiation, pluripotency, chromatin dynamics and cell reprogramming processes, with plenty of new targets identified in the last decade. Besides this role in tissue homeostasis, one enthralling feature of AHR is its capacity of acting as an oncogene or tumor suppressor depending on the specific organ, tissue and cell type. Together with its well-known modulation of cell adhesion and migration in a cell-type specific manner in epithelial-mesenchymal transition (EMT), this duality has also contributed to the arise of its clinical interest, highlighting a new potential as therapeutic tool, diagnosis and prognosis marker. Therefore, a deregulation of AHR-controlled pathways may have a causal role in contributing to physiological and homeostatic failures, tumor progression and dissemination. With that firmly in mind, this review will address the remarkable capability of AHR to exert a different function influenced by the phenotype of the target cell and its potential consequences.

13 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ANAna Nacarino-Palma
Ana Nacarino-Palma
CRClaudia María Rejano-Gordillo
Claudia María Rejano-Gordillo
FRFrancisco Javier González Rico
Francisco Javier González Rico
AOAna Ordiales-Talavero
Ana Ordiales-Talavero
ÁRÁngel Carlos Román
Ángel Carlos Román
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
Non-small cell lung adenocarcinoma (NSCLC) bearing K-RasG12D mutations is one of the most prevalent types of lung cancer worldwide. Aryl hydrocarbon receptor (AHR) expression varies in human lung tumors and has been associated with either increased or reduced lung metastasis. In the mouse, Ahr also adjusts lung regeneration upon injury by limiting the expansion of resident stem cells. Here, we show that the loss of Ahr enhances K-RasG12D-driven NSCLC in mice through the amplification of stem cell subpopulations. Consistent with this, we show that K-RasG12D;Ahr−/− lungs contain larger numbers of cells expressing markers for both progenitor Clara (SCGB1A1 and CC10) and alveolar type-II (SFTPC) cells when compared to K-RasG12D;Ahr+/+-driven tumors. They also have elevated numbers of cells positive for pluripotent stem cells markers such as SOX2, ALDH1, EPCAM, LGR5 and PORCN. Typical pluripotency genes Nanog, Sox2 and c-Myc were also upregulated in K-RasG12D;Ahr−/− lung tumors as found by RNAseq analysis. In line with this, purified K-RasG12D/+;Ahr−/− lung cells generate larger numbers of organoids in culture that can subsequently differentiate into bronchioalveolar structures enriched in both pluripotency and stemness genes. Collectively, these data indicate that Ahr antagonizes K-RasG12D-driven NSCLC by restricting the number of cancer-initiating stem cells. They also suggest that Ahr expression might represent a good prognostic marker to determine the progression of K-RasG12D-positive NSCLC patients.

16 May 2025 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
FRFrancisco Javier González Rico
Francisco Javier González Rico
JZJiyue Zhu
Jiyue Zhu
GPGuangyong Peng
Guangyong Peng
Phenotype (SASP) (Campisi and d'Adda di 2007). A key driver of celular senesence is the progressive shortening of telomeres that occurs with aging. Additionally, cells can enter senescence in response to various stressprs, including sustained mitogenic signaling, oncogene activation, DNA damage from irradiation, oxidative and genotoxic stress, epigenetic alterations, chromatin disorganization, perturbed proteostasis, mitochondrial dysfunction, inflammation signals, tissue damage, chemotherapeutic agents, and nutrient deprivation (Kumari and Jat, 2021).Both cellular senescence and organismal aging are closely conected to epigenetic states.During development, epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, collectively determine cellular differentiation status and cell fates. These differentiation states can also be reversed through the transcriptional and/or epigentic reprogramming of the cell. In cell reprogramming, the cell identity and plasticity can be altered by the overexpression of transcription factors such as Oct4, Sox2, Klf4 and c-Myc (OSKM) (Takahashi and Yamanaka, 2006). This induction creates a dedifferentiation state that enhances tissue regeneration and has been succesfully applied in various pathological contexts, including diabetes, muscle injuries, retinal degeneration, and myocardial infartion (Ocampo et al., 2016;Lu et al., 2020;Chen et al., 2021). Those We hope that the articles featured in this research topic will serve as valuable resources for researchers in the fields of aging, senescence, and cell reprogramming, whether they are well-established experts or newcomers eager to explore this exciting arena.

29 September 2026 in Molecular Biomedicine
Verified
Journal Article
Open access
PDF file
BMBeatriz Marín-Díaz
Beatriz Marín-Díaz
FRFrancisco Javier González Rico
Francisco Javier González Rico
LOLaura Ordóñez-Mata
Laura Ordóñez-Mata
ÁRÁngel C. Román
Ángel C. Román
JMJaime M. Merino
Jaime M. Merino
DSDr. Pedro M. Fernández Salguero
Dr. Pedro M. Fernández Salguero
Aryl hydrocarbon receptor (AhR) is a transcription factor traditionally involved in toxicological and carcinogenic cellular processes linked to xenobiotics. In recent decades, a new physiological role has emerged, in which AhR has been shown to be a key regulator of different processes such as the cell cycle, cell proliferation, apoptosis, pluripotency, and stemness. Recent studies have suggested a possible role for AhR in the DNA damage response (DDR) and repair mechanisms. To assess this point, in this work we used diethylnitrosamine (DEN) to induce liver injury and DNA damage in wild type (WT) and AhR knockout (KO) mice. We analysed the protein expression levels of several DDR (H2AX, 53BP1, and BRCA1) and cell proliferation (Ki67, AFP, and PCNA) markers. Therefore, we demonstrate that following DNA damage, the absence of AhR results in a shift towards apoptosis and compensatory proliferation mechanisms, accompanied by reduced repair fidelity of DNA damage compared with than in WT mice, compromising genomic stability. We also mapped the interactome profile of AhR, identifying new partners involved in both repair and proliferation processes. In conclusion, our results highlight the relevant role of AhR in cell proliferation and DNA repair processes, which can be key in different pathologies, such as cancer.